An invalid vocabulary is selected. Please change it in the options.
Title Creditssort ascending Start date - Expiration date
Monthly Oncology Tumor Boards: Management of Pheochromocytoma and Paraganglioma 1.00 06/29/2023 - 12:00am to 07/21/2024 - 12:00am
Case Studies in the Management of Leukemia 0.75 12/01/2023 - 12:00am to 12/01/2024 - 12:00am
Evaluating Immune Checkpoint Inhibition Response Biomarkers 0.75 06/15/2023 - 12:00am to 06/15/2024 - 12:00am
Prophylactic Vaccines/Immunizations for Cancer Patients 0.75 08/04/2022 - 12:00am to 08/04/2024 - 12:00am
Clinical Scenario #1: Applying Biomarkers in Risk Stratification of Localized Prostate Cancer 0.75 06/15/2023 - 12:00am to 06/15/2024 - 12:00am
Management of Toxicities of BTK Inhibitors in B-Cell Malignancies 0.75 12/01/2023 - 12:00am to 12/01/2024 - 12:00am
Psychotherapeutic Strategies and Pharmacotherapy Options for Addressing Distress in Cancer Patients 0.75 08/04/2022 - 12:00am to 08/04/2024 - 12:00am
Clinical Scenario #2: Applying Biomarkers in Breast Cancer 0.75 06/15/2023 - 12:00am to 06/15/2024 - 12:00am
Clinical Scenario #3: Applying Biomarkers in Central Nervous System Cancers 0.75 06/15/2023 - 12:00am to 06/15/2024 - 12:00am
Chronic Myeloid Leukemia/Myelofibrosis: TKI Therapy and Toxicity Management 0.75 12/01/2023 - 12:00am to 12/01/2024 - 12:00am
Clinical Scenario #4: Applying Biomarkers in Non-Small Cell Lung Cancer 0.75 06/15/2023 - 12:00am to 06/15/2024 - 12:00am
Clinical Scenario #5: Applying Biomarkers in Biliary Tract Cancers 0.75 06/15/2023 - 12:00am to 06/15/2024 - 12:00am
Diagnosis and Management of Breast Cancer: What does the Evidence Show, What are We Doing, And What’s on the Horizon? 0.75 03/31/2023 - 12:00am to 03/31/2024 - 12:00am
Comorbidities, Dosing Issues, Polypharmacy, and Adverse Effects in Breast Cancer 0.50 05/03/2023 - 12:00am to 03/31/2024 - 12:00am
Management of Newly Diagnosed Multiple Myeloma Based on Risk Stratification 0.50 12/01/2023 - 12:00am to 12/01/2024 - 12:00am

Pages